Scholarlink

Background <p>While fetal hypoxia-ischemia is a known trigger for meconium aspiration syndrome (MAS), many infants develop MAS without it, suggesting other risk factors. We examined the association between MAS and the presence and severity of fetal inflammatory response (FIR) on placental histopathology.</p> Methods/Study design <p>A single-center retrospective cohort study of term infants with meconium-stained amniotic fluid (MSAF) born at Parkland Hospital (2010–2018). Maternal and infant demographics and clinical data were recorded. Placental histopathologic evidence of FIR was classified per Amsterdam criteria. MAS was defined as respiratory distress in an infant with MSAF requiring NICU admission and ≥48 hours of respiratory support and/or radiographic findings of MAS.</p> Results <p>Among 1,696 term neonates with MSAF, 118 (6.9%) developed MAS. Univariate analysis showed that MAS was associated with post-term delivery, non-reassuring fetal heart patterns, cesarean delivery, thick meconium, low Apgar scores, severe acidosis, and presence of FIR (all <i>P</i> &lt; 0.001). On multivariate analysis, FIR remained significant (adjusted OR 2.50, 95% CI 1.41–4.82). Moderate to severe FIR conferred 5-times higher odds for developing MAS (adjusted OR 5.43, 95% CI 2.83–10.40).</p> Conclusion <p>FIR, particularly its severity, is an independent predictor of MAS, highlighting intrauterine inflammation as a key mechanism alongside hypoxia-ischemia.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Fetal Inflammatory Response (FIR) is independently associated with Meconium Aspiration Syndrome (MAS)</p> </ItemContent> <ItemContent> <p>Increasing severity of FIR confers progressively higher risk of MAS.</p> </ItemContent> <ItemContent> <p>This is the first study to demonstrate a dose-response relationship between FIR severity on MAS.</p> </ItemContent> <ItemContent> <p>These observations highlight the role of intrauterine inflammation in MAS pathogenesis and provide new insight into its impact on term neonates.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fetal inflammatory response severity on placental histology identifies neonates at risk for meconium aspiration syndrome

  • 期刊论文

  • 发表日期：

    2025年12月4日

查看全文
  • Roberto Gonzalez,
  • Steven Brown,
  • Julide Sisman,
  • Manahil Firdaus,
  • Zehra Yusuf,
  • Lina Chalak,
  • Vishal Kapadia,
  • Imran Mir

摘要

Background

While fetal hypoxia-ischemia is a known trigger for meconium aspiration syndrome (MAS), many infants develop MAS without it, suggesting other risk factors. We examined the association between MAS and the presence and severity of fetal inflammatory response (FIR) on placental histopathology.

Methods/Study design

A single-center retrospective cohort study of term infants with meconium-stained amniotic fluid (MSAF) born at Parkland Hospital (2010–2018). Maternal and infant demographics and clinical data were recorded. Placental histopathologic evidence of FIR was classified per Amsterdam criteria. MAS was defined as respiratory distress in an infant with MSAF requiring NICU admission and ≥48 hours of respiratory support and/or radiographic findings of MAS.

Results

Among 1,696 term neonates with MSAF, 118 (6.9%) developed MAS. Univariate analysis showed that MAS was associated with post-term delivery, non-reassuring fetal heart patterns, cesarean delivery, thick meconium, low Apgar scores, severe acidosis, and presence of FIR (all P < 0.001). On multivariate analysis, FIR remained significant (adjusted OR 2.50, 95% CI 1.41–4.82). Moderate to severe FIR conferred 5-times higher odds for developing MAS (adjusted OR 5.43, 95% CI 2.83–10.40).

Conclusion

FIR, particularly its severity, is an independent predictor of MAS, highlighting intrauterine inflammation as a key mechanism alongside hypoxia-ischemia.

Impact

Fetal Inflammatory Response (FIR) is independently associated with Meconium Aspiration Syndrome (MAS)

Increasing severity of FIR confers progressively higher risk of MAS.

This is the first study to demonstrate a dose-response relationship between FIR severity on MAS.

These observations highlight the role of intrauterine inflammation in MAS pathogenesis and provide new insight into its impact on term neonates.